Vivian Jaber

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “microRNA-Based Biomarkers in Alzheimer’s Disease (AD)”.

microRNA-Based Biomarkers in Alzheimer’s Disease (AD)

Frontiers in Neuroscience(2020)10.3389/fnins.2020.585432

N/A

0DataRank · unranked

99 citations

Vivian Jaber, Peter N. Alexandrov, Andrea Vergallo, Simone Lista, Harald Hampel +2 more

Lipopolysaccharides (LPSs) as Potent Neurotoxic Glycolipids in Alzheimer’s Disease (AD)

International Journal of Molecular Sciences(2022)10.3390/ijms232012671

N/A

0DataRank · unranked

57 citations

Vivian Jaber, Aileen I. Pogue, Nathan M. Sharfman, Christopher E. Taylor, Walter J. Lukiw +1 more

Downregulation of Neurofilament Light Chain Expression in Human Neuronal-Glial Cell Co-Cultures by a Microbiome-Derived Lipopolysaccharide-Induced miRNA-30b-5p

Frontiers in Neurology(2022)10.3389/fneur.2022.900048

N/A

0DataRank · unranked

17 citations

Vivian Jaber, Nathan M. Sharfman, Yuhai Zhao, Walter J. Lukiw, Aileen I. Pogue

SARS-CoV-2 Invasion and Pathological Links to Prion Disease

Biomolecules(2022)10.3390/biom12091253

N/A

0DataRank · unranked

17 citations

Vivian Jaber, Aileen I. Pogue, Yuhai Zhao, Walter J. Lukiw

SARS-CoV-2, long COVID, prion disease and neurodegeneration

Frontiers in Neuroscience(2022)10.3389/fnins.2022.1002770

N/A

0DataRank · unranked

16 citations

Vivian Jaber, Walter J. Lukiw, Yuhai Zhao

Alteration of Biomolecular Conformation by Aluminum-Implications for Protein Misfolding Disease

Molecules(2022)10.3390/molecules27165123

N/A

0DataRank · unranked

12 citations

Aileen I. Pogue, Peter N. Alexandrov, Leslie G. Butler, Wenhong Li, Vivian Jaber +2 more

Current advances in our understanding of circular RNA (circRNA) in Alzheimer’s disease (AD); the potential utilization of synthetic circRNAs as a therapeutic strategy in the clinical management of AD

Frontiers in Drug Discovery(2022)10.3389/fddsv.2022.983030

N/A

0DataRank · unranked

9 citations

Vivian Jaber, Walter J. Lukiw, Yuhai Zhao